Cinctive Capital Management LP Incyte Corp Transaction History

Cinctive Capital Management LP

  • $1.72 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
BUY
$70.23 - $86.01 $329,308 - $403,300
4,689 New
4,689 $338,000
Q2 2022

Aug 15, 2022
SELL
$66.18 - $83.18 $1.65 Million - $2.08 Million
-25,000 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$66.02 - $79.71 $1.65 Million - $1.99 Million
25,000 New
25,000 $1.99 Million

Others Institutions Holding INCY

# of Institutions
659
Shares Held
186M
Call Options Held
714K
Put Options Held
557K
View Full List

About INCYTE CORP

INCY Quotes by TradingView
  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16.4B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Cinctive Capital Management LP Portfolio

Follow Cinctive Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cinctive Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Cinctive Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email